1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Petit, M.C.
Benkirane, N.
Guichard, G.
Phan Chan Du, A.
Cung, M.T.
Briand, J.P.
Muller, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
D-ALANINE
D-peptide linking
C6 H15 N4 O2 1
175.209
D-ARGININE
D-peptide linking
C4 H7 N O4
133.103
D-ASPARTIC ACID
D-peptide linking
C5 H10 N2 O3
146.144
D-GLUTAMINE
D-peptide linking
C6 H13 N O2
131.173
D-LEUCINE
D-peptide linking
C9 H11 N O2
165.189
D-PHENYLALANINE
D-peptide linking
C5 H9 N O2
115.130
D-PROLINE
D-peptide linking
C3 H7 N O3
105.093
D-SERINE
D-peptide linking
C5 H11 N O2
117.146
D-VALINE
D-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C7 H12 O4
160.168
ISOBUTYL MALONIC ACID
non-polymer
H2 N
16.023
AMINO GROUP
non-polymer
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
274
3686
3692
10.1074/jbc.274.6.3686
9920919
Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site. Structural basis for its antigenic cross-reactivity with the parent peptide.
1999
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
RETRO-INVERSO PEPTIDE CORRESPONDING TO THE MAJOR IMMUNOGEN REGION OF THE FOOT-AND-MOUTH-DISEASE VIRUS CAPSID
1973.200
VP1 PROTEIN
THE MAJOR IMMUNOGEN REGION, RESIDUES 141-159
1
man
polymer
no
yes
(LML)(DGN)(DAR)(DAL)(DVA)(DAR)(DPR)(DAL)(DLE)(DSN)G(DPN)(DAS)G(DAR)(DVA)G(DSN)G
(NH2)
XQRAVRPALSGFDGRVGSGX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1999-01-13
1
1
2008-03-27
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1998-05-22
REL
REL
LEAST RESTRAINTS VIOLATIONS, TARGET FUNCTION
50
10
COSY
TOCSY NOESY
ROESY
0.1 M PHOSPHATE
5.7
1
atm
285
K
RESTRAINT ENERGY MINIMIZATION
TORSION ANGLE DYNAMICS, ANNEALING, MINIMIZATION
90% H2O:10% D2O
GUNTERT,WUTHRICH
refinement
DYANA
1.4
structure solution
DYANA
1.4
400
Bruker
DRX400
LML
159
n
1
LML
159
A
DGN
158
n
2
DGN
158
A
DAR
157
n
3
DAR
157
A
DAL
156
n
4
DAL
156
A
DVA
155
n
5
DVA
155
A
DAR
154
n
6
DAR
154
A
DPR
153
n
7
DPR
153
A
DAL
152
n
8
DAL
152
A
DLE
151
n
9
DLE
151
A
DSN
150
n
10
DSN
150
A
GLY
149
n
11
GLY
149
A
DPN
148
n
12
DPN
148
A
DSP
147
n
13
DAS
147
A
GLY
146
n
14
GLY
146
A
DAR
145
n
15
DAR
145
A
DVA
144
n
16
DVA
144
A
GLY
143
n
17
GLY
143
A
DSN
142
n
18
DSN
142
A
GLY
141
n
19
GLY
141
A
NH2
140
n
20
NH2
140
A
author_defined_assembly
1
monomeric
A
DGN
158
D-GLUTAMINE
A
DGN
2
GLN
A
DAR
157
D-ARGININE
A
DAR
3
ARG
A
DAL
156
D-ALANINE
A
DAL
4
ALA
A
DVA
155
D-VALINE
A
DVA
5
VAL
A
DAR
154
D-ARGININE
A
DAR
6
ARG
A
DPR
153
D-PROLINE
A
DPR
7
PRO
A
DAL
152
D-ALANINE
A
DAL
8
ALA
A
DLE
151
D-LEUCINE
A
DLE
9
LEU
A
DSN
150
D-SERINE
A
DSN
10
SER
A
DAS
147
D-ASPARTIC ACID
A
DAS
13
ASP
A
DAR
145
D-ARGININE
A
DAR
15
ARG
A
DVA
144
D-VALINE
A
DVA
16
VAL
A
DSN
142
D-SERINE
A
DSN
18
SER
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
DGN
158
127.25
72.91
1
A
DAR
157
144.31
70.43
1
A
DAL
156
154.87
-69.39
1
A
DLE
151
132.44
77.82
1
A
DAS
147
165.48
-69.26
1
A
DSN
142
163.99
-99.89
2
A
DAR
157
144.44
70.33
2
A
DAL
156
166.60
-69.92
2
A
DAR
154
170.34
-62.68
2
A
DAL
152
42.67
-98.41
2
A
DLE
151
142.64
55.53
2
A
DSN
150
152.73
-85.71
2
A
DAS
147
165.88
-66.18
2
A
DAR
145
170.52
-116.76
2
A
DVA
144
69.41
-98.66
3
A
DAR
157
169.20
84.36
3
A
DAL
156
157.29
-68.56
3
A
DAR
154
170.58
-65.04
3
A
DAL
152
25.13
-95.02
3
A
DSN
150
36.87
-108.17
3
A
DAS
147
164.18
-67.84
3
A
DAR
145
170.42
-141.52
4
A
DGN
158
125.66
154.41
4
A
DAR
157
95.86
83.24
4
A
DLE
151
131.99
65.01
4
A
DPN
148
37.79
-157.55
4
A
DAS
147
163.68
-65.30
4
A
DAR
145
27.77
-97.08
5
A
DAR
154
170.82
-59.69
5
A
DAL
152
9.04
-90.67
5
A
DLE
151
146.67
42.79
5
A
DSN
150
170.44
-132.29
5
A
DAS
147
166.53
-69.32
5
A
DAR
145
170.47
-141.40
5
A
DSN
142
166.37
-109.68
6
A
DAR
157
165.06
83.68
6
A
DAL
152
57.00
-106.80
6
A
DLE
151
140.47
58.05
6
A
DAS
147
168.26
-58.74
6
A
DAR
145
170.50
-141.50
6
A
DSN
142
164.26
-112.56
7
A
DAL
156
170.27
-66.15
7
A
DAR
154
170.07
-62.90
7
A
DAL
152
52.14
-95.39
7
A
DLE
151
139.09
70.03
7
A
DAS
147
166.24
-64.55
7
A
DAR
145
170.75
-109.34
7
A
DVA
144
55.09
-91.43
8
A
DGN
158
125.56
154.30
8
A
DAR
157
37.48
83.55
8
A
DAR
154
170.37
-62.66
8
A
DAL
152
41.12
-97.98
8
A
DLE
151
144.10
48.54
8
A
DAS
147
163.73
-70.49
8
A
DAR
145
170.55
-116.71
8
A
DSN
142
170.30
-131.98
9
A
DAR
157
169.12
83.66
9
A
DAR
154
170.16
-62.55
9
A
DAL
152
53.73
-97.13
9
A
DLE
151
138.93
51.57
9
A
DAS
147
164.60
-71.05
9
A
DAR
145
170.46
-141.54
10
A
DGN
158
170.05
40.52
10
A
DAR
157
149.04
83.65
10
A
DAR
154
171.47
-64.07
10
A
DAL
152
49.47
-94.14
10
A
DLE
151
141.23
49.79
10
A
DAS
147
165.12
-71.31
10
A
DAR
145
170.08
-137.20
model building
DYANA
refinement
DYANA
VP1 PROTEIN
RETRO-INVERSO ANALOGUE OF THE G-H LOOP OF VP1 IN FOOT-AND-MOUTH-DISEASE (FMD) VIRUS, NMR, 10 STRUCTURES
1
Y
N
covale
1.325
A
LML
159
A
C
LML
1
1_555
A
DGN
158
A
N
DGN
2
1_555
covale
1.325
A
DGN
158
A
C
DGN
2
1_555
A
DAR
157
A
N
DAR
3
1_555
covale
1.325
A
DAR
157
A
C
DAR
3
1_555
A
DAL
156
A
N
DAL
4
1_555
covale
1.325
A
DAL
156
A
C
DAL
4
1_555
A
DVA
155
A
N
DVA
5
1_555
covale
1.326
A
DVA
155
A
C
DVA
5
1_555
A
DAR
154
A
N
DAR
6
1_555
covale
1.360
A
DAR
154
A
C
DAR
6
1_555
A
DPR
153
A
N
DPR
7
1_555
covale
1.325
A
DPR
153
A
C
DPR
7
1_555
A
DAL
152
A
N
DAL
8
1_555
covale
1.325
A
DAL
152
A
C
DAL
8
1_555
A
DLE
151
A
N
DLE
9
1_555
covale
1.325
A
DLE
151
A
C
DLE
9
1_555
A
DSN
150
A
N
DSN
10
1_555
covale
1.324
A
DSN
150
A
C
DSN
10
1_555
A
GLY
149
A
N
GLY
11
1_555
covale
1.325
A
DPN
148
A
N
DPN
12
1_555
A
GLY
149
A
C
GLY
11
1_555
covale
1.325
A
DPN
148
A
C
DPN
12
1_555
A
DAS
147
A
N
DAS
13
1_555
covale
1.325
A
DAS
147
A
C
DAS
13
1_555
A
GLY
146
A
N
GLY
14
1_555
covale
1.325
A
DAR
145
A
N
DAR
15
1_555
A
GLY
146
A
C
GLY
14
1_555
covale
1.326
A
DAR
145
A
C
DAR
15
1_555
A
DVA
144
A
N
DVA
16
1_555
covale
1.325
A
DVA
144
A
C
DVA
16
1_555
A
GLY
143
A
N
GLY
17
1_555
covale
1.325
A
DSN
142
A
N
DSN
18
1_555
A
GLY
143
A
C
GLY
17
1_555
covale
1.325
A
DSN
142
A
C
DSN
18
1_555
A
GLY
141
A
N
GLY
19
1_555
covale
1.326
A
NH2
140
A
N
NH2
20
1_555
A
GLY
141
A
C
GLY
19
1_555
VIRAL PROTEIN
CAPSID, PEPTIDOMIMETIC, RETRO-INVERSO, FMDV, ANTIGEN, Viral protein
1BFW
PDB
1
1BFW
159
140
1BFW
159
140
1BFW
A
1
1
20
1
P 1